Exagen Dividends
| XGN Stock | USD 4.05 0.05 1.22% |
As of the 26th of November 2024, Dividends Paid is likely to grow to about 12 M, while Dividend Yield is likely to drop 0.02. Exagen's past performance could be the main factor of why investors trade Exagen Inc stock today. Investors should clearly understand every aspect of the Exagen dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Exagen's dividend schedule and payout information. Exagen Inc dividends can also provide a clue to the current valuation of Exagen.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 11.4 M | 12 M | |
| Dividend Yield | 0.02 | 0.02 | |
| Dividend Payout Ratio | (0.50) | (0.53) | |
| Dividend Paid And Capex Coverage Ratio | (17.47) | (18.34) |
Exagen |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Exagen must own a stock before its ex-dividend date to receive its next dividend.
Exagen Dividends Paid Over Time
Today, most investors in Exagen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Exagen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Exagen dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Exagen Historical Dividend Yield Growth
A solid dividend growth pattern of Exagen could indicate future dividend growth is likely, which can signal long-term profitability for Exagen Inc. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Exagen Inc dividend as a percentage of Exagen stock price. Exagen Inc dividend yield is a measure of Exagen stock productivity, which can be interpreted as interest rate earned on an Exagen investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exagen. If investors know Exagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exagen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 3.163 | Quarterly Revenue Growth 0.066 | Return On Assets (0.17) | Return On Equity (0.70) |
The market value of Exagen Inc is measured differently than its book value, which is the value of Exagen that is recorded on the company's balance sheet. Investors also form their own opinion of Exagen's value that differs from its market value or its book value, called intrinsic value, which is Exagen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exagen's market value can be influenced by many factors that don't directly affect Exagen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exagen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Exagen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exagen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.